SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-003316
Filing Date
2021-01-26
Accepted
2021-01-26 16:51:32
Documents
1
Period of Report
2021-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4084
  Complete submission text file 0000899243-21-003316.txt   5626
Mailing Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104
Business Address C/O ARCH VENTURE PARTNERS 999 THIRD AVENUE, SUITE 3400 SEATTLE WA 98104 857-400-4222
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BIOVERATIV INC. 225 SECOND AVENUE WALTHAM MA 02451
Business Address
Brudnick Richard (Reporting) CIK: 0001692359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39615 | Film No.: 21554755